<![CDATA[Brand Republic]]><![CDATA[The Week in Healthcare]]>http://www.brandrepublic.com/news/1117195/Week-Healthcare/<![CDATA[Voluntary Sector: The Week in Charities]]>http://www.brandrepublic.com/features/1071732/Voluntary-Sector-Week-Charities/<![CDATA[Public Affairs: The Week in Lobbying]]>http://www.brandrepublic.com/features/1071729/Public-Affairs-Week-Lobbying/<![CDATA[Healthcare: On the agenda - NICE backs ovarian cancer blood test]]>http://www.brandrepublic.com/news/1068113/Healthcare-agenda---NICE-backs-ovarian-cancer-blood-test/<![CDATA[Voluntary Sector: The Week in Charities]]>http://www.brandrepublic.com/features/1062921/Voluntary-Sector-Week-Charities/<![CDATA[Voluntary Sector: The Week in Charities]]>http://www.brandrepublic.com/features/1042871/Voluntary-Sector-Week-Charities/<![CDATA[Ovarian Cancer Action launches online awareness campaign]]>http://www.brandrepublic.com/news/989439/Ovarian-Cancer-Action-launches-online-awareness-campaign/<![CDATA[Healthcare: On the Agenda - Delays in ovarian cancer diagnosis]]>http://www.brandrepublic.com/features/931144/Healthcare-Agenda---Delays-ovarian-cancer-diagnosis/<![CDATA[On the Agenda - Delays in ovarian cancer diagnosis]]>http://www.brandrepublic.com/news/931350/Agenda---Delays-ovarian-cancer-diagnosis/<![CDATA[The week in marketing]]>http://www.brandrepublic.com/news/928004/week-marketing/